Axiom Veterinary Laboratory News Letter SPRING 2002

  HOME

 

 

 

Spring 2002

P650 PACKING INSTRUCTION
Packing Compliance- 650
Packing Instruction 650
The London Laboratory
Results by E-mail
Vet Nurse Training
Quality Standards
New Website
FOR YOUR INFORMATION………………
Mast Cell Tumours
Test Improvements 
Important Notice on Sample Tube Confusion
OTHER AXIOM NEWSLETTERS

 

 

 


All Axiom Newsletters are copyright ©
 ALL IRELAND SERVICE
 ALLERGY TESTING
 BSAVA CPD MEETINGS
 CASE STUDIES
 COMPANY INFORMATION
 CONTACT THE LAB
 ECVCP TRAINING
 ENDOCRINE FACT SHEETS
 HAEMATOLOGY IMAGES
  ISO 9001 STATEMENT
 LABORATORY GUIDE
 LONDON LABORATORY
 MICRO/CYTO/HAEM IMAGES
NEWS LETTERS
 PACKING INSTRUCTION [P650]
 PET OWNERS LEAFLETS
 PRESS RELEASE
 PRICE LIST (details only)
 SITE MAP
 ST. HELENS LABORATORY
 USEFUL VET LINKS
 VACANCIES @ AXIOM
 VET NURSE TRAINING
 OUR LOCATION
 WHO'S WHO @ AXIOM

 
Packing Compliance- 650 

From January 1st 2002 there will be some new packing instructions for the transmission of diagnostic specimens through the post or by courier (Packaging Instruction 650) - Several years ago the Post Office became concerned about packaging and tried to force on the profession without consultation the use of IATA packing regulation 602 for infectious specimens. This new packing instruction is a result of widespread consultation and achieves a degree of practicality as well as conforming to HSE regulations. We have been busy on your behalf assessing these new packaging instructions for diagnostic specimens. The good news is that both sets of polystyrene sampling kits supplied by Axiom conform to Packaging Instruction 650. If our packaging is used correctly you can be confident that as the consignor you will be meeting the Health and Safety requirements for the transmission of your samples.

To improve the safe transmission of specimens to us by our established clients we are currently producing new packaging specifically for histologies, urine and faecal samples, and swabs. The sending of histology specimens with formalin through the post poses additional risks. Our new compliant packaging will be available in the New Year and will be provided free of charge to Axiom clients on a pro rata usage basis.

NEW range of packaging 

PLEASE NOTE: jiffy bags or envelopes containing unprotected specimens do not meet the requirements of the new regulations. Practices should avoid using these or risk possible prosecution under HSE legislation. Practices using the expensive IATA 602 packaging for infectious specimens can continue to do so but should note that more cost effective and practical options are available.

NOTE: Those clients who send samples to us via a courier are not exempt from the Packing Instruction 650 and should use suitable approved packaging. Please ring us and speak with Mrs. Sue Turton if you have any queries relating to the new requirements. She will also be happy to provide you with copies of the instruction or alternatively you may wish to visit our
web site.
  

back to top of the page

Packing Instruction 650 - the Package 

P650 PACKING INSTRUCTION
This packing instruction applies to UN 3373.

General provisions
Diagnostic specimens shall be packed in good quality packagings, which shall be strong enough to withstand the shocks and loadings normally encountered during transport, including trans-shipment between transport units and between transport units and warehouses as well as any removal from a pallet or overpack for subsequent manual or mechanical handling. Packagings shall be constructed and closed so as to prevent any loss of contents when prepared for transport which might be caused under normal conditions of transport, by vibration, or by changes in temperature, humidity or pressure.

Primary receptacles shall be packed in secondary packagings in such a
way that, under normal conditions of transport, they cannot break, be
punctured or leak their contents into the secondary packaging. Secondary packagings shall be secured in outer packagings with suitable cushioning material. Any leakage of the contents shall not substantially impair
the protective properties of the cushioning material or of the outer
packaging.

For transport each package shall be clearly and durably marked with the words "DIAGNOSTIC SPECIMENS".

The completed package shall be capable of successfully passing the drop test in 6.3.2.5 as specified in 6.3.2.3 and 6.3.2.4 except that the height of the drop shall not be less than 1.2 m.

For Liquids
The primary receptacle(s) shall be leakproof and shall not contain more than 500 ml.

There shall be absorbent material placed between the primary receptacle and the secondary packaging; if several fragile primary receptacles are placed in a single secondary packaging, they shall be either individually wrapped or separated so as to prevent contact between them. The absorbent material, such as cotton wool, shall be in sufficient quantity to absorb the entire contents of the primary receptacles and there shall be a secondary packaging which shall be leakproof.

The primary receptacle or the secondary packaging shall be capable of withstanding without leakage an internal pressure producing a pressure differential of not less than 95 kPa (0.95 bar).

The outer packaging shall not contain more than 4 litres.

For Solids
The primary receptacle(s) shall be siftproof and shall not contain more than 500 g.

If several fragile primary receptacles are placed in a single secondary packaging, they shall be either individually wrapped or separated so as to prevent contact between them and there shall be a secondary packaging which shall be leakproof.

The outer packaging shall not contain more than 4 kg.

Provided that diagnostic specimens are packed in accordance with  this packing instruction, no other requirements of these regulations shall apply.

back to top of the page

The London Laboratory 
As a result of increased demand for our services our London Laboratory is about to undergo some refurbishment, which will greatly enhance the same day service. We are revamping the physical environment of the laboratory in January which, with updated facilities, will enable us to offer clients the assurance of reliability and a more flexible and extensive same day test menu. As part of the continuing expansion of the service, we have already introduced a same day feline TT4 screening test for hyperthyroidism. Our range of courier services will be extended once the refurbishment is complete.
For further details please contact Peter Webb - mailto:peter.webb@axiomvetlab.co.uk
Results by E-mail

We hope that you will agree that the problems we experienced with 'irritable faxing syndrome' have now been ameliorated and the dispatch of results is much improved. We are continuing to introduce systems to ensure that communication to our clients is robust and efficient. We offer several methods to complement your own systems including e-mail, which is becoming a very popular and reliable method of communicating results.

It also has the added benefit of allowing you to cut and paste results into patient files in a 'windows-based' environment. It is also quicker and saves you paper!
For further information on e-mailing please phone John Thipthorpe on 01626 771432 or mailto:admin@axiomvetlab.co.uk
 

Vet Nurse Training 

We are receiving some very gratifying feedback from Vet Nurses who have taken advantage of our 'bespoke' training. We believe we are able to offer a very specialised approach to individual needs by avoiding a course 'set in stone' and responding to individual requirements at any particular time.

One to one training with our highly qualified and experienced Heads of Department facilitates confidence building and very quickly identifies areas in need of attention. Please ring us for more information or visit our web page - http://www.axiomvetlab.com/Vet Nurse Training.html 

Quality Standards 

As you are aware we are continually assessed every 6 months to ensure that we meet our documented quality standards. Part of the inspection is a review of our quality control records and performance on those external quality assessment schemes to which we subscribe. We have maintained a rigorous approach to this and our results reflect the input. We welcome and encourage visits to the laboratory so that clients can see at first hand our operations and quality checks. If you are interested in meeting our clinical pathologists and technical staff please contact us and we will be happy to make arrangements for your visit.

Please keep up the dialogue. We rely on your comments and feedback to respond to your requirements!

New Website 
Our Web site http://www.axiomvetlab.com is up and running and contains a wealth of information. It is still being remodelled as we continually review its functionality. Unlike our competitors our price list is not presented on this public site as we feel this would be a breach of professional confidence. The price list is available by request in various formats, our CD-Rom, Printed, Microsoft Word, HTML and Rich text. The latter versions can be e-mailed to you on request and are suitable for incorporation into just about every practice system.

back to top of the page

 FOR YOUR INFORMATION………………
Mast Cell Tumours 

Mast cell tumours are the most common cutaneous tumour in the dog, accounting for 16%-21% of all skin tumours. They are the second most common cutaneous tumour in the cat. They tend to occur in older dogs (mean age approximately 9 years). Boxers, Boston terriers, Labrador retrievers, beagles and schnauzers appear to be at increased risk. Most tumours occur on the trunk but up to 25% can occur on the limbs. Figures A and B were taken from a firm, well circumscribed mass over the lateral aspect of the left hind limb of a 6 year old Labrador.

Mast cell tumours involve the dermis and subcutaneous tissues. They can be graded histologically as undifferentiated (high) grade, intermediate and well differentiated (low) grade (grades 1, 2 and 3 respectively using the Bostock grading system). Histological grade generally provides a good indicator of metastatic potential. High grade tumours metastasise first to local lymph nodes and then to spleen and liver. Bone marrow and peripheral blood involvement can occur with disseminated anaplastic visceral mast cell tumours (disseminated mastocytosis) which are almost always preceded by an undifferentiated primary cutaneous lesion. Well differentiated mast cell tumours are usually solitary and slow growing. Undifferentiated tumours tend to grow rapidly, are larger and very often ulcerated. Surrounding tissues may become inflamed and oedematous.

The most common complication associated with mast cell tumours relates to the release of histamine from the mast cell granules which can result in gastrointestinal ulceration. Coagulation abnormalities may also occur as a result of heparin release from degranulated mast cells. Localised haemorrhage at the time of surgery can occur as a result of tumour manipulation resulting in mast cell degranulation.

How useful is cytology?
The majority of mast cell tumours can be diagnosed on the basis of fine needle aspiration cytology since the neoplastic cells exfoliate readily (Figs A and B). The drainage lymph node can also be aspirated to check for evidence of tumour metastasis (note however that a low number of mast cells can be present in normal lymph nodes and in nodes responding to antigenic stimulation).

Cytological grading of mast cell tumours has not been fully assessed. The mast cells in poorly differentiated tumours tend to be larger, are sparsely granulated, and contain nuclei with one or more nucleoli. In contrast, mast cells from low grade tumours usually have densely packed cytoplasmic granules which may obscure nuclear detail (note, however, that some of these 'well differentiated' tumours have been shown to be malignant). It is important to realise, therefore, that cytology at best provides only a semi-objective assessment of malignancy and that histopathological examination is always necessary to grade these tumours more precisely.

Prognosis and treatment
All mast cell tumours should be regarded as potentially malignant and wide margin (at least 3 cm) surgical excision is indicated. Histological grade is the most consistent prognostic indicator in canine mast cell tumours. 80%-90% of dogs with well differentiated mast cell tumours and approximately 60%-75% of those with intermediate grade tumours experience long term survival following surgical excision. Recurrence or metastasis following surgical excision of undifferentiated tumours is common. Dogs with regional lymph node involvement and/or those which are showing systemic signs also have a poorer prognosis.

Mast cell tumours in the cat
A relatively small percentage of cutaneous mast cell tumours in the cat are malignant. Two types of cutaneoous mast cell tumour have been described; mastocytic mast cell tumours and histiocytic mast cell tumours. The latter typically occur in young cats. Siamese cats are predisposed to both histological types. The histiocytic tumours are often multiple and may regress spontaneously.

Visceral mast cell tumours in the cat comprise approx-imately 50% of all mast cell tumours. These frequently involve the spleen, liver and/or intestine and, in contrast to the cutaneous forms, widespread dissemination and metastasis is common. Many cats are leukaemic (i.e. neoplastic mast cells are in the circulation) at the time of presentation and the prognosis is much more guarded. Peripheral eosinophilia and basophilia may be observed and examination of a buffy coat preparation to check for the presence of mast cells may also be potentially helpful in these animals, unless of course they are overtly leukaemic at the time of presentation.

Figure A shows the typical cytological appearance of a mast cell tumour. The mast cells in this instance appear well differentiated and contain densely packed azurophilic cytoplasmic granules which are obscuring nuclear detail. Free mast cell granules can be seen in the background. Eosinophils are also present. In Figure B the elongated spindle-shaped cell is a fibroblast. Fibroblasts are often seen in fine needle aspirates from mast cell tumours.

References to the Mast Cell section
Small Animal Clinical Oncology. S.J. Withrow and E. Gregory MacEwen. 3rd Edition. W.B. Saunders Co. 2001.
Diagnostic Cytology and Hematology of the Dog and Cat. R.L. Cowell, R.D. Tyler and J.H. Meinkoth. 2nd Edition. Mosby, Inc. 1999.
Colour Atlas of Cytology of the Dog and Cat. R. Baker and J.H. Lumsden. Mosby, Inc. 2000.

back to top of the page

Test Improvements 

Calculi analysis: In the light of advances in nutritional studies and the increasing choice of dietary formulations, we have reviewed calculi analysis methods, with the result that we are now offering analysis only by x-ray crystallography. The previous semi-quantitative methodology provided reliable total stone composition analysis but as it was unable to differentiate the composite layers we feel clients will be better served by this improved methodology. Mr. Tony Bacon, Head of Microbiology, will be happy to discuss any queries you may have.

Topscreen: With the manufacture of a new batch of the Topscreen screening test we have decided to remove the food panel, as there is no scientific evidence to justify its retention. Most of you will be aware it is impossible to diagnose food allergy/ intolerance/hypersensitivity by either in vitro or in vivo testing. Ed Hall in a recent issue of Vet Times commented "Tests based on measuring food specific IgG are probably worthless" whilst IgE tests "have yet to be properly validated". We agree with his comments and most other studies generally express the same opinion. The only sure way of diagnosing food-associated skin disease (which includes dietary allergy/hypersensitivity and intolerance) is by the use of elimination diets (and rechallenge). Home cooked diets are best for diagnostic purposes. Please do not hesitate to call Peter Webb for further advice on this topic.

Pro-ANP 31-67: This relatively new peptide assay is a useful diagnostic aid in naturally occurring canine heart failure. It requires separated heparinised plasma for valid results. Please be aware that values are decreased if serum is sent and values are significantly depressed if unseparated whole blood is sent. It is also important not to refrigerate samples but to send them immediately. Call any of our Clinical Pathologists for more advice.
Or visit our web site page - Vetsign CardioScreen

Endocrinology: With the introduction of Free T4 (by dialysis) our RIA department has been very busy, so much so that it has been necessary to increase our radioactivity disposal licence. In addition, we are now also offering a canine sex hormone alopecia profile (consisting of cortisol, androstendione, oestradiol, progesterone, 17-OH progesterone and testosterone) to help with those mysteriously balding dogs! We have also started to prepare a series of endocrinology factsheets covering common small animal endocrine diseases with a summary of their aetiology, clinical presentation and which diagnostic tests to use (as well as which ones not to use!). If you would like any of the factsheets (click here for Endocrine Fact Sheets) then please just get in touch. If there are any other matters regarding the endocrinology service that you would like to discuss, please contact: Diagnostic Support mailto:admin@axiomvetlab.co.uk     

 back to top of the page

Important Notice on Sample Tube Confusion 

Sample tube confusion: With the distribution of many different types of sample tubes and sources from both Europe and the USA, we have been alerted to current confusion and potential disaster concerning sample tube top colour. The supplier of our microtubes has been very helpful in loosely defining colour codes as follows:  

   USA  Europe
 Serum/plain     

 red

 clear
 Serum gel       

 brown yellow

 brown
 Heparin     

 green

orange
 Heparin gel    

 green

 green  orange  green
 OXF     

 grey

 yellow
 EDTA   

 mauve pink 

 red pink 
 Citrate

 blue

 green

PLEASE NOTE: that these colours relate to many different suppliers. We have been informed that as yet there are no defined colour code standards and in the opinion of the suppliers it will be some time before this happens.

In view of the confusion, which could arise we would strongly advise that you check the tubes before use rather than relying on identification by colour only.             

back to top of the page


AXIOM'S  NEWSLETTERS 
AUTUMN 2000  SUMMER 2001 SPRING 2002 SUMMER 2002 SUMMER 2003
SPRING 2004 SPRING 2005 SUMMER 2005 AUTUMN 2005  SPRING 2006 
SUMMER 2006  SPRING 2007 BSAVA 2007    

 ALLERCEPT available at Axiom

 Guildhay VETSIGN Canine Cardio Screen

"We look forward to providing our clients with continued support and innovation in clinical pathology"

Axiom Veterinary Laboratories Ltd.
The Manor House, Brunel Road, Newton Abbot, Devon TQ12 4PB, UK.
TEL: +44 (0)1626 355655 FAX: +44 (0)1626 357750/1 E-mail:admin@axiomvetlab.co.uk
 

Copyright © 2007 Axiom Veterinary Laboratories Limited. All Rights Reserved.
Designated trademarks are the property of their respective owners.